| Name | Title | Contact Details |
|---|
St. Tammany Parish Hospital delivers today`s life-improving procedures with the latest technology, highest quality and the utmost care to area residents. From wellness and prevention to diagnosis, treatment, rehabilitation and recovery, the St. Tammany Parish Hospital system delivers the very latest technology, the most accomplished specialists and highly personalized, caring staff to ensure patients and their families receive world-class healthcare close to home. St. Tammany has higher quality ratings from The Joint Commission (qualitycheck.org) than other hospitals in our region. STPH consistently earns national and local recognition for quality, innovation and patient satisfaction from Press Ganey, Reuters Thomson, VHA Leadership Awards, Employer of Choice, Best Places to Work and Best of the Northshore rankings. Please tell any member of the staff, a supervisor or the Guest Services Department (898-4669) if there is anything we can do to make a patient`s stay more comfortable. We want the opportunity to address it. St. Tammany Parish Hospital is accredited by The Joint Commission, whose standards deal with quality and safety of care and environment. Patients have the right to contact the Joint Commission`s Office of Quality Monitoring for concerns about your care either by calling (800) 994-6610 or by visiting jointcommission.org/. You may also speak with the Louisiana Department of Health and Hospitals by calling (225) 342-6429 or the U.S. Department of Health and Human Services at (877) 696-6775. St. Tammany Parish Hospital campuses are completely tobacco-free. As the largest healthcare provider in the parish, we eliminated tobacco as part of our mission to serve the community`s healthcare needs. We recognize adults` right to use tobacco but we know its ill effects and institute this policy for the safety and health of our patients, families, employees, volunteers and physicians. Thank you for not smoking. STPH is a self-supporting not-for-profit community hospital; it receives no tax funding.
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
Since 1965, Brown Medical Industries has manufactured quality, innovative orthopaedic products, including ingenious SEAL-TIGHT cast and bandage moisture protectors and the historically strong-selling Plastalume finger, arm and leg splints.
CenterCare Inc is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.